Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 226

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer

Open access
Zhao, Lian, Yu, Haibo, Yi, Shuijing, Peng, Xiaowei, Su, Peng, Xiao, Zhiming, Liu, Rui, Tang, Anliu, Li, Xiayu, Liu, Fen, Shen, Shourong · 2016 · Oncotarget

Abstract

// Lian Zhao 1, 2 , Haibo Yu 3 , Shuijing Yi 4 , Xiaowei Peng 5 , Peng Su 1, 2 , Zhiming Xiao 1 , Rui Liu 1 , Anliu Tang 1, 2 , Xiayu Li 1, 2 , Fen Liu 1, 2 , Shourong Shen 1, 2 1 Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China 2 Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Changsha, Hunan, China 3 Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China 4 Department of Gynaecology and Obstetrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China 5 Department of Breast Oncology Plastic and Head and Neck, The Affiliated Cancer Hospital of Xiangya Medical School, Hunan, China Correspondence to: Haibo Yu, e-mail: yuhaibo616@163.com Keywords: miR-138-5p, PD-L1, tumor suppressor, colorectal cancer, biomarker Received: August 21, 2015 Accepted: May 13, 2016 Published: May 27, 2016 ABSTRACT microRNAs (miRNAs) play critical roles in cancer development and progression. This study investigated the effects of miR-138-5p in human colorectal cancer (CRC) development. miR-138-5p was frequently downregulated in CRC tissues and was associated with advanced clinical stage, lymph node metastasis and poor overall survival. We found that miR-138-5p decreased expression of programmed cell death ligand 1 (PD-L1) through interaction with its PD-L1 3′ untranslated region. miR-138-5p also dramatically suppressed CRC cell growth in vitro and inhibited tumorigenesis in vivo . PD-L1 and miR-138-5p levels were inversely correlated in human CRC tumors, and miR-138-5p inhibited PD-L1 expression in tumor models. These results suggest that miR-138-5p is a tumor suppressor in CRC, and its effects are exerted at least partially through PD-L1 downregulation. Low miR-138-5p and high PD-L1 levels correlated with shorter overall CRC patient survival, indicating that miR-138-5p and PD-L1 may serve as CRC biomarkers for risk group assignment, optimal therapy selection and clinical outcome prediction. Targeting PD-L1, possibly by administering miR-138-5p mimics, might be a clinically effective anti-CRC therapeutic strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.9659

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 226

Metadata

Authors
Zhao, L., Yu, H., Yi, S., Peng, X., Su, P., Xiao, Z., Liu, R., Tang, A., Li, X., Liu, F., & Shen, S.
Venue
Oncotarget
Published
2016-05-27
Volume
7
Issue
29
Pages
45370-45384
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2404282441
Cited by
226
References
4
FWCI
8.98
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.